No ‘easy’ weight loss: don’t overlook the social cost of anti-obesity drugs

Alexandra Brewis () and Sarah Trainer ()

Nature, 2024, vol. 626, issue 7998, 258-260

Abstract: Ideas of diet and exercise as the ‘best’ way to lose weight could stigmatize people taking Ozempic, WeGovy and other blockbuster drugs that affect appetite. Lessons from weight-loss surgery reveal ways to help.

Keywords: Obesity; Society; Human behaviour (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-024-00329-9 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:626:y:2024:i:7998:d:10.1038_d41586-024-00329-9

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-024-00329-9

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().